Novartis International AG /
Swissmedic approves Novartis'' new heart failure medicine Entresto(TM)
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
* Decision by Swiss Health Authority follows US Food and Drug ...
↧